Search

2 result(s) for 'author#Maxime Ronot' within BMC

1. Lipiodol retention pattern after TACE for HCC is a predictor for local progression in lesions with complete response

   To evaluate the predictive value of the lipiodol retention pattern for local progression of HCC with a complete response (CR) on CT according to mRECIST criteria after a first session of conventional chemoembo...

   Authors: Marco Dioguardi Burgio, Riccardo Sartoris, Claudia Libotean, Magaly Zappa, Annie Sibert, Valérie Vilgrain and Maxime Ronot

   Citation: Cancer Imaging 2019 19:75

   Content type: Research article Published on: 15 November 2019

   • View Full Text
   • View PDF

2. Radioembolisation with yttrium‒90 microspheres versus sorafenib for treatment of advanced hepatocellular carcinoma (SARAH): study protocol for a randomised controlled trial

   Untreated advanced hepatocellular carcinoma (HCC) is linked to poor prognosis. While sorafenib is the current recommended treatment for advanced HCC, radioembolisation (RE; also called selective internal radia...

   Authors: Valérie Vilgrain, Mohamed Abdel-Rehim, Annie Sibert, Maxime Ronot, Rachida Lebtahi, Laurent Castéra and Gilles Chatellier

   Citation: Trials 2014 15:474

   Content type: Study protocol Published on: 3 December 2014

   • View Full Text
   • View PDF